Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Golden Throat Holdings Group Co Ltd ( (HK:6896) ) is now available.
Golden Throat Holdings Group Co Ltd reported a significant decline in its financial performance for the first half of 2025, with revenue dropping by 39.1% to RMB319.2 million and gross profit decreasing by 37.1% to RMB246.3 million compared to the same period in 2024. The company also saw a 37.6% reduction in profit attributable to equity holders, amounting to RMB83.7 million, and decided not to declare an interim dividend, reflecting challenges in its operational and market environment.
The most recent analyst rating on (HK:6896) stock is a Buy with a HK$4.00 price target. To see the full list of analyst forecasts on Golden Throat Holdings Group Co Ltd stock, see the HK:6896 Stock Forecast page.
More about Golden Throat Holdings Group Co Ltd
Golden Throat Holdings Group Co Ltd is a company incorporated in the Cayman Islands, primarily engaged in the production and sale of healthcare products, particularly throat lozenges, which are well-known in the Chinese market.
Average Trading Volume: 1,456,313
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.74B
See more data about 6896 stock on TipRanks’ Stock Analysis page.